Back to Search
STEVEN TREON, MD, PHD
MD, PHD
Specialist
NPI: 1821060138Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
79961(MA)
Research & Publications (20)
Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.
PMID 19506160·J Clin Oncol·2009
3-trial
Advances in the biology and treatment of Waldenström's macroglobulinemia: a report from the 5th International Workshop on Waldenström's Macroglobulinemia, Stockholm, Sweden.
PMID 19362961·Clin Lymphoma Myeloma·2009
8-other
Lenalidomide and rituximab in Waldenstrom's macroglobulinemia.
PMID 19118065·Clin Cancer Res·2009
3-trial
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.
PMID 19015393·Blood·2009
3-trial
Waldenstrom's macrogloblinemia/ lymphoplasmacytic lymphoma.
PMID 18283788·Cancer Treat Res·2008
6-review
Novel agents in the treatment of Waldenström's macroglobulinemia.
PMID 17877845·Clin Lymphoma Myeloma·2007
6-review
Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248.
PMID 17545538·Clin Cancer Res·2007
3-trial
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia.
PMID 16410453·Blood·2006
8-other
Report of the Third International Workshop on Waldenstrom's macroglobulinemia.
PMID 15794850·Clin Lymphoma·2005
8-other
CHOP plus rituximab therapy in Waldenstrom's macroglobulinemia.
PMID 15794864·Clin Lymphoma·2005
3-trial
Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia.
PMID 15659493·J Clin Oncol·2005
3-trial
Clinical responses to sildenafil in Waldenstrom's macroglobulinemia.
PMID 15636699·Clin Lymphoma·2004
5-case
Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom's macroglobulinemia.
PMID 15367407·Ann Oncol·2004
3-trial
Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerations.
PMID 12720146·Semin Oncol·2003
8-other
Tumor Cell Expression of CD59 Is Associated With Resistance to CD20 Serotherapy in Patients With B-Cell Malignancies.
PMID 11395643·J Immunother (1991)·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY ST..
BOSTON, MA 02115 - Phone
- (617) 632-4166
Quick Facts
- NPI
- 1821060138
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile